Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 229
Filter
1.
J Dent Res ; 102(3): 349-356, 2023 03.
Article in English | MEDLINE | ID: mdl-36437532

ABSTRACT

Dental occlusion requires harmonious development of teeth, jaws, and other elements of the craniofacial complex, which are regulated by environmental and genetic factors. We performed the first genome-wide association study (GWAS) on dental development (DD) using the Demirjian radiographic method. Radiographic assessments from participants of the Generation R Study (primary study population, N1 = 2,793; mean age of 9.8 y) were correlated with ~30 million genetic variants while adjusting for age, sex, and genomic principal components (proxy for population stratification). Variants associated with DD at genome-wide significant level (P < 5 × 10-8) mapped to 16q12.2 (IRX5) (lead variant rs3922616, B = 0.16; P = 2.2 × 10-8). We used Fisher's combined probability tests weighted by sample size to perform a meta-analysis (N = 14,805) combining radiographic DD at a mean age of 9.8 y from Generation R with data from a previous GWAS (N2 = 12,012) on number of teeth (NT) in infants used as proxy of DD at a mean age of 9.8 y (including the ALSPAC and NFBC1966). This GWAS meta-analysis revealed 3 novel loci mapping to 7p15.3 (IGF2BP3: P = 3.2 × 10-8), 14q13.3 (PAX9: P = 1.9 × 10-8), and 16q12.2 (IRX5: P = 1.2 × 10-9) and validated 8 previously reported NT loci. A polygenic allele score constructed from these 11 loci was associated with radiographic DD in an independent Generation R set of children (N = 703; B = 0.05, P = 0.004). Furthermore, profiling of the identified genes across an atlas of murine and human stem cells observed expression in the cells involved in the formation of bone and/or dental tissues (>0.3 frequency per kilobase of transcript per million mapped reads), likely reflecting functional specialization. Our findings provide biological insight into the polygenic architecture of the pediatric dental maturation process.


Subject(s)
Genome-Wide Association Study , Tooth , Infant , Humans , Child , Animals , Mice , Alleles , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide/genetics , Genetic Loci
2.
Clin Chim Acta ; 519: 183-186, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33933427

ABSTRACT

Measurements of thyroid stimulating hormone (TSH) and free thyroxine (fT4) are critical for the early detection of thyroid diseases and for monitoring treatment. The IFCC Committee for Standardization of Thyroid Function Tests (C-STFT) established reference systems for TSH harmonization and FT4 standardization, and is now working national partners on implementing these reference systems. These implementation activities include the maintenance of the reference systems, their use to standardize and harmonize assays, and educational activities to inform stakeholders about anticipated changes in measurement values as a result of standardization and harmonization. The IFCC C-STFT formed a network of reference laboratories for FT4 and is creating a new harmonization panel for TSH. The U.S. Centers for Disease Control and Prevention is a member of the reference laboratory network and is launching a formal standardization program for FT4. In Japan, national organizations successfully implemented TSH harmonization and established harmonized reference intervals for TSH. The C-STFT made available on its website research findings about potential concerns, communication needs and benefits of FT4 standardization and is assisting local organizations with communicating changes related to these standardization and harmonization efforts. Implementation of fT4 standardization and TSH harmonization is a complex, continuous task that requires collaboration with IVD manufacturers, laboratories, physicians and health care providers. C-STFT is working successfully with national organizations and local groups on improving FT4 and TSH measurements.


Subject(s)
Thyroid Diseases , Thyroid Function Tests , Humans , Japan , Reference Values , Thyrotropin , Thyroxine
3.
Res Vet Sci ; 130: 118-125, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32172000

ABSTRACT

Bovine tuberculosis (bTB) is caused by Mycobacterium bovis and disseminated worldwide. In Argentina, the highest prevalence occurs in dairy areas. BoLA DRB3.2 is related to the adaptive immunity in mycobacterial infections. Genetic polymorphisms of this marker have been associated with resistance or susceptibility to bovine diseases. We evaluated the association between BoLA DRB3.2 polymorphisms and bTB pathology scores in dairy and beef cattle breeds of Argentina. Most bovines exhibited visible lesions compatible with tuberculosis and, furthermore, 150 (85.7%) were also positive by bacteriology. A pathology index showed a variable degree of disease, from 3 to 76 (median pathology score = 9 (IQR: 7-15)). Thirty-five BoLA DRB3.2 alleles were identified with an associated frequency from 16% to 0.3%, distributed 73% (n = 128) in heterozygosis and 27% (n = 47) in homozygosis, with 12 BoLA DRB3.2 alleles (*0101, *1101, *1501, *0201, *2707 *1001, *1002, *1201, *14011, *0501 *0902 and *0701) representing the 74.7% of the population variability. A functional analysis grouped them in 4 out of 5 clusters (A-D), suggesting a functional overlapping. Among the 90 identified genotypes, *1101/*1101, *1101/*1501 and *0101/*0101 were the most frequent (10%, 8.9% and 8.9%, respectively). No association was detected between the pathology scores and a specific DRB3.2 allele (p > .05). Animals infected with M. bovis spoligotype SB0153 showed a significantly higher pathology score than those affected by the spoligotype SB0145 (p = .018). Furthermore, the Aberdeen Angus breed exhibited highest pathological scores (p < .0001), which were associated with disseminated lesion, thus suggesting that the host component could be important to the disease progression.


Subject(s)
Genotype , Histocompatibility Antigens Class II/genetics , Polymorphism, Genetic , Tuberculosis, Bovine/pathology , Alleles , Animals , Argentina , Cattle , Exons , Female , Histocompatibility Antigens Class II/metabolism , Male , Nucleotides , Tuberculosis, Bovine/genetics
4.
BMC Res Notes ; 11(1): 257, 2018 Apr 25.
Article in English | MEDLINE | ID: mdl-29695260

ABSTRACT

OBJECTIVE: Guided self-help treatments based on cognitive behavioral therapy (CBT-GSH) are regarded as a first-line effective treatment for bulimia nervosa (BN). With limited application for CBT-GSH in Japanese clinical settings, we conducted a single arm pilot study in order to confirm the acceptability and availability of CBT-GSH in Japan. RESULTS: 25 women with BN received 16-20 sessions of face-to-face CBT-GSH. Primary outcomes were the completion rate of intervention and abstinence rates from objective bingeing and purging as assessed by the Eating Disorder Examination. Secondary outcomes were other self-report measurements of the frequency of bingeing and purging, and characteristic psychopathologies of eating disorders. Assessments were conducted before CBT as baseline as well as after CBT. 92% (23/25) of the participants completed the CBT sessions. After CBT-GSH, 40% (10/25) of the participants (intention-to-treat) achieved symptom abstinence. The mean binge and purge episodes during the previous 28 days improved from 21.88 to 10.96 (50% reduction) and from 22.44 to 10.88 (52% reduction), each (before CBT-GSH to after CBT-GSH), and the within-group effect sizes were medium (Cohen's d = 0.67, 0.65, each). Our study provided a preliminary evidence about the feasibility of CBT-GSH in Japanese clinical settings for the future. Trial registration This study was registered retrospectively in the national UMIN Clinical Trials Registry on July 10, 2013 (registration ID: UMIN000011120).


Subject(s)
Bulimia Nervosa/therapy , Cognitive Behavioral Therapy/methods , Outcome Assessment, Health Care , Self Care/methods , Adolescent , Adult , Feasibility Studies , Female , Humans , Japan , Pilot Projects , Young Adult
5.
J Dent Res ; 96(10): 1153-1161, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28489485

ABSTRACT

Eph receptors belong to a subfamily of receptor tyrosine kinases that are activated by membrane-spanning ligands called ephrins. Previously, we demonstrated that the ephrinB1-EphB2 interaction regulates odontogenic/osteogenic differentiation from dental pulp cells (DPCs) in vitro. The goal of this study was to identify the molecular mechanisms regulated by the EphB2/ephrinB1 system that govern tertiary dentin formation in vitro and in vivo. During tooth development, ephrinB1, and EphB2 were expressed in preodontoblast and odontoblasts at postnatal day 4. EphrinB1 was continuously expressed in odontoblasts and odontoblastic processes until the completion of tooth eruption. In addition, ephrinB1 was expressed in odontoblastic processes 2 wk following tooth injury without pulp exposure, whereas EphB2 was expressed in the center of pulp niches but not odontoblasts. In a model of tooth injury with pulp exposure, ephrinB1 was strongly expressed in odontoblasts 4 wk postinjury. In vitro studies with human and mouse DPCs treated with calcium hydroxide (CH) or mineral trioxide aggregate (MTA) showed an increased expression of insulin-like growth factor 1 (IGF-1). Experiments using several inhibitors of IGF-1 receptor signaling revealed that inhibiting the Ras/Raf-1/MAPK pathway inhibited EphB2 expression, and inhibiting the PI3K/Akt/mTOR pathway specifically inhibited ephrinB1 gene expression. Tooth injury in mice with odontoblast-specific IGF-1 receptor ablation exhibited a reduced tertiary dentin volume, mineral density, and ephrinB1 expression 4 wk following injury. We conclude that the IGF-1/ephrinB1 axis plays significant roles in the early stages of tooth injury. Further research is needed to fully understand the potential of targeting ephrinB1 as a regenerative pulp therapy.


Subject(s)
Dentin/metabolism , Dentinogenesis/physiology , Ephrin-B1/metabolism , Insulin-Like Growth Factor I/metabolism , Odontoblasts/metabolism , Aluminum Compounds/pharmacology , Animals , Calcium Compounds/pharmacology , Calcium Hydroxide/pharmacology , Dental Pulp/metabolism , Drug Combinations , Humans , Male , Mice , Mice, Inbred C57BL , Models, Animal , Oxides/pharmacology , Signal Transduction , Silicates/pharmacology
6.
Genes Brain Behav ; 14(3): 301-9, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25704122

ABSTRACT

DNA methylation is one of the essential factors in the control of gene expression. Alteration of the DNA methylation pattern has been linked to various neurological, behavioral and neurocognitive dysfunctions. Recent studies have pointed out the importance of epigenetics in brain development and functions including learning and memory. Nutrients related to one-carbon metabolism are known to play important roles in the maintenance of genomic DNA methylation. Previous studies have shown that the long-term administration of a diet lacking essential one-carbon nutrients such as methionine, choline and folic acid (methyl donors) caused global DNA hypermethylation in the brain. Therefore, the long-term feeding of a methyl-donor-deficient diet may cause abnormal brain development including learning and memory. To confirm this hypothesis, 3-week-old mice were maintained on a folate-, methionine- and choline-deficient (FMCD) or control (CON) diet for 3 weeks. We found that the methyl-donor deficiency impaired both novel object recognition and fear extinction after 3 weeks of treatment. The FMCD group showed spontaneous recovery of fear that differed from that in CON. In addition, we found decreased Gria1 gene expression and specific CpG hypermethylation of the Gria1 promoter region in the FMCD hippocampus. Our data suggest that a chronic dietary lack of methyl donors in the developmental period affects learning, memory and gene expressions in the hippocampus.


Subject(s)
Choline Deficiency/genetics , Choline Deficiency/psychology , Folic Acid Deficiency/genetics , Folic Acid Deficiency/psychology , Hippocampus/physiology , Memory/physiology , Methionine/deficiency , Age Factors , Animals , Choline/administration & dosage , Choline Deficiency/blood , DNA Methylation , Diet , Epigenesis, Genetic , Folic Acid/administration & dosage , Folic Acid Deficiency/blood , Hippocampus/growth & development , Hippocampus/metabolism , Homocysteine/blood , Methionine/administration & dosage , Methionine/blood , Mice , Mice, Inbred C57BL , Models, Animal , Nutritional Requirements , Promoter Regions, Genetic , Receptors, AMPA/biosynthesis , Receptors, AMPA/genetics , Receptors, Glutamate/biosynthesis , Receptors, Glutamate/genetics
7.
Transl Psychiatry ; 2: e186, 2012 Nov 13.
Article in English | MEDLINE | ID: mdl-23149450

ABSTRACT

Panic disorder (PD) is a moderately heritable anxiety disorder whose pathogenesis is not well understood. Due to the lack of power in previous association studies, genes that are truly associated with PD might not be detected. In this study, we conducted a genome-wide association study (GWAS) in two independent data sets using the Affymetrix Mapping 500K Array or Genome-Wide Human SNP Array 6.0. We obtained imputed genotypes for each GWAS and performed a meta-analysis of two GWAS data sets (718 cases and 1717 controls). For follow-up, 12 single-nucleotide polymorphisms (SNPs) were tested in 329 cases and 861 controls. Gene ontology enrichment and candidate gene analyses were conducted using the GWAS or meta-analysis results. We also applied the polygenic score analysis to our two GWAS samples to test the hypothesis of polygenic components contributing to PD. Although genome-wide significant SNPs were not detected in either of the GWAS nor the meta-analysis, suggestive associations were observed in several loci such as BDKRB2 (P=1.3 × 10(-5), odds ratio=1.31). Among previous candidate genes, supportive evidence for association of NPY5R with PD was obtained (gene-wise corrected P=6.4 × 10(-4)). Polygenic scores calculated from weakly associated SNPs (P<0.3 and 0.4) in the discovery sample were significantly associated with PD status in the target sample in both directions (sample I to sample II and vice versa) (P<0.05). Our findings suggest that large sets of common variants of small effects collectively account for risk of PD.


Subject(s)
Genome-Wide Association Study , Panic Disorder/genetics , Adult , Asian People/genetics , Case-Control Studies , Female , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Multifactorial Inheritance , Polymorphism, Single Nucleotide
8.
J Dent Res ; 91(3): 268-74, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22180568

ABSTRACT

Bisphosphonates are therapeutic agents in the treatment of post-menopausal osteoporosis. Although they have been associated with delayed healing in injured tissues, inappropriate femoral fractures, and osteonecrosis of the jaw (ONJ), the pathophysiological mechanisms involved are not clear. Our hypothesis is that alendronate, a member of the N-containing bisphosphonates, indirectly inhibits osteoblast function through the coupling of osteoclasts to osteoblasts by ephrinB-EphB interaction. We found that alendronate increased gene and protein expression of ephrinB1 and EphB1, as well as B3, in femurs of adult mice injected with alendronate (10 µg/100 g/wk) for 8 weeks. Alendronate suppressed the expression of bone sialoprotein (BSP) and osteonectin in both femurs and bone marrow osteoblastic cells of mice. After elimination of pre-osteoclasts from bone marrow cells, alendronate did not affect osteoblast differentiation, indicating the need for pre-osteoclasts for alendronate's effects. Alendronate stimulated EphB1 and EphB3 protein expression in osteoblasts, whereas it enhanced ephrinB1 protein in pre-osteoclasts. In addition, a reverse signal by ephrinB1 inhibited osteoblast differentiation and suppressed BSP gene expression. Thus, alendronate, through its direct effects on the pre-osteoclast, appears to regulate expression of ephrinB1, which regulates and acts through the EphB1, B3 receptors on the osteoblast to suppress osteoblast differentiation.


Subject(s)
Alendronate/pharmacology , Bone Density Conservation Agents/pharmacology , Bone Remodeling/drug effects , Cell Communication/drug effects , Ephrin-B1/metabolism , Receptors, Eph Family/metabolism , Animals , Cells, Cultured , Collagen Type I/antagonists & inhibitors , Gene Expression Regulation , Integrin-Binding Sialoprotein/antagonists & inhibitors , Mice , Mice, Inbred C57BL , Osteoblasts/drug effects , Osteoblasts/metabolism , Osteoclasts/drug effects , Osteoclasts/metabolism , Osteonectin/antagonists & inhibitors
9.
Radiol Med ; 116(2): 211-8, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20574708

ABSTRACT

PURPOSE: It has been reported that the prognosis differs between patients who have collagen vascular diseaseassociated interstitial pneumonia (CVD-IP) and those with idiopathic IP (IIP). In this study, chest computed tomography (CT) findings were compared between patients with CVD-IP and IIP. MATERIALS AND METHODS: A retrospective analysis was performed of 47 consecutive patients (23 with CVD-IP and 24 with IIP). The lower-lobe volume (LLV), total lung volume (TLV), and their ratio (LLV/TLV) were determined by volumetry using three-dimensional computed tomography (CT). RESULTS: There was no significant difference of the LLV/TLV ratio between the CVD-IP and IIP groups. However, the LLV/TLV ratio was <0.33 in 9/23 patients with CVD-IP versus 2/24 patients with IIP, and there was a significant difference in the percentage of patients with a ratio<0.33 between the CVD-IP and IIP groups (p = 0.01). The LLV/TLV ratio was not influenced by the severity of lung disease. CONCLUSIONS: Measuring the LLV/TLV ratio by threedimensional CT can help distinguish between CVD-IP and IIP at initial diagnosis, especially in patients with CVD-IP who have pulmonary involvement before other organ diseases and symptoms caused by CVD.


Subject(s)
Collagen Diseases/diagnostic imaging , Imaging, Three-Dimensional , Lung Diseases, Interstitial/diagnostic imaging , Tomography, X-Ray Computed/methods , Vascular Diseases/diagnostic imaging , Aged , Case-Control Studies , Collagen Diseases/pathology , Female , Humans , Lung Diseases, Interstitial/pathology , Lung Volume Measurements , Male , Middle Aged , Prognosis , Respiratory Function Tests , Retrospective Studies , Vascular Diseases/pathology
10.
Clin Nephrol ; 70(4): 348-53, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18826862

ABSTRACT

AIM: To contribute to understanding the pathogenesis of hyperkalemia that often occurs in patients with diabetes. MATERIALS AND METHODS: We describe 3 familial cases of mitochondrial diabetes mellitus. The mitochondrial A3243G point mutation was confirmed in a mother and her 2 children. We examined their clinical features and pathological findings, and assessed heteroplasmy of mutant mitochondria DNA (mtDNA) by molecular analysis. RESULTS: The second son had spontaneous hyperkalemia and hyporeninemic hypoaldosteronism. Histopathological examination revealed severe tubulointerstitial and vascular changes around the juxtaglomerular apparatus. The mother only showed intermittent hyperkalemia concurrently with the aggravation of heart failure, and the pathological changes in her kidneys were mild. Heteroplasmy was more severe in the second son than in the mother. CONCLUSION: Heteroplasmy of mitochondrial cytopathy combined with diabetes mellitus led to abnormalities resembling those seen in Type IV renal tubular acidosis.


Subject(s)
Hyperkalemia/genetics , Mitochondrial Myopathies/genetics , Adult , Aged , Cardiomyopathies/genetics , Deafness/genetics , Diabetes Mellitus/genetics , Female , Humans , Hypoaldosteronism/genetics , Male
11.
Eur Respir J ; 32(1): 105-12, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18321934

ABSTRACT

Clock genes regulate mammalian circadian rhythms, and dysfunction of clock genes can contribute to various disorders. To investigate whether obstructive sleep apnoea syndrome (OSAS) influences clock gene function, the present authors examined Period1 (Per1) mRNA expression in vitro and in vivo. In eight healthy subjects and eight OSAS patients, plasma noradrenaline, serum interleukin (IL)-6, high-sensitivity C-reactive protein (hsCRP) and Per1 mRNA expression in peripheral whole blood were measured. Expression of Per1 mRNA in cultured cells was examined under IL-6 or noradrenaline stimulation in vitro. After noradrenaline was administered to mice in vivo, Per1 mRNA expression in the brain was examined. The concentrations of serum IL-6, hsCRP and plasma noradrenaline were elevated in OSAS patients, but improved by continuous positive airway pressure (CPAP) therapy. Per1 mRNA expression in the peripheral blood significantly decreased at 02:00 h by CPAP in OSAS patients. Stimulation with IL-6 did not directly induce Per1 mRNA in vitro. Administration of noradrenaline induced Per1 mRNA in the cerebral cortex of mice in vivo. The current study revealed that obstructive sleep apnoea syndrome caused clock gene dysfunction, and continuous positive airway pressure helped to improve it. Sympathetic activation and elevation of the plasma noradrenaline concentration in obstructive sleep apnoea syndrome may be one of the factors involved in disorders of Period1 mRNA expression.


Subject(s)
Cell Cycle Proteins/metabolism , Chronobiology Disorders/genetics , Circadian Rhythm/genetics , Nuclear Proteins/metabolism , Sleep Apnea Syndromes/complications , Adult , Animals , Case-Control Studies , Cell Cycle Proteins/genetics , Cells, Cultured , Chronobiology Disorders/therapy , Continuous Positive Airway Pressure , Female , Fibroblasts , Humans , Interleukin-6/physiology , Leukocytes , Male , Mice , Middle Aged , Norepinephrine/physiology , Nuclear Proteins/genetics , Period Circadian Proteins , RNA, Messenger/metabolism
12.
Br J Cancer ; 98(5): 907-14, 2008 Mar 11.
Article in English | MEDLINE | ID: mdl-18283321

ABSTRACT

The purpose of this study was to evaluate the efficacy of gefitinib and the feasibility of screening for epidermal growth factor receptor (EGFR) mutations among select patients with advanced non-small cell lung cancer (NSCLC). Stage IIIB/IV NSCLC, chemotherapy-naive patients or patients with recurrences after up to two prior chemotherapy regimens were eligible. Direct sequencing using DNA from tumour specimens was performed by a central laboratory to detect EGFR mutations. Patients harbouring EGFR mutations received gefitinib. The primary study objective was response; the secondary objectives were toxicity, overall survival (OS), progression-free survival (PFS), 1-year survival (1Y-S) and the disease control rate (DCR). Between March 2005 and January 2006, 118 patients were recruited from 15 institutions and were screened for EGFR mutations, which were detected in 32 patients--28 of whom were enrolled in the present study. The overall response rate was 75%, the DCR was 96% and the median PFS was 11.5 months. The median OS has not yet been reached, and the 1Y-S was 79%. Thus, gefitinib chemotherapy in patients with advanced NSCLC harbouring EGFR mutations was highly effective. This trial documents the feasibility of performing a multicentre phase II study using a central typing laboratory, demonstrating the benefit to patients of selecting gefitinib treatment based on their EGFR mutation status.


Subject(s)
Carcinoma, Non-Small-Cell Lung/drug therapy , ErbB Receptors/genetics , Lung Neoplasms/drug therapy , Mutation , Quinazolines/therapeutic use , Adenocarcinoma, Bronchiolo-Alveolar/drug therapy , Adenocarcinoma, Bronchiolo-Alveolar/genetics , Aged , Aged, 80 and over , Carcinoma, Non-Small-Cell Lung/genetics , Disease Progression , Female , Gefitinib , Gene Amplification , Humans , Lung Neoplasms/genetics , Male , Middle Aged , Prospective Studies , Quinazolines/adverse effects
13.
Gait Posture ; 27(1): 97-102, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17408954

ABSTRACT

To elucidate the effect on movement-related potentials (MRPs) of anticipatory postural adjustments (APAs) accompanied by voluntary focal movement, we examined the MRPs of shoulder flexion movement under standing and sitting postural conditions in 12 normal subjects. MRPs were evaluated based on three components: readiness potential (RP), motor potential (MP), and movement-monitoring potential. APAs were observed in the activities of postural muscles including the biceps femoris and erector spinae muscles only under standing conditions. The amplitudes of the three MRP components were larger under standing conditions than under sitting conditions for all recorded electrode positions, and the RP and MP amplitudes at the vertex position, which lies over the supplementary motor area (SMA), showed a prominent increase under standing conditions with the highest statistical significance. These results suggest that a recruited neural process of the cortical area including the SMA may be necessary to generate voluntary movement accompanied by APA.


Subject(s)
Postural Balance/physiology , Posture/physiology , Upper Extremity/physiology , Adult , Arm/physiology , Electroencephalography , Electromyography , Evoked Potentials, Motor/physiology , Female , Humans , Male , Motor Cortex/physiology , Movement/physiology , Muscle, Skeletal/physiology , Recruitment, Neurophysiological/physiology , Rectus Abdominis/physiology , Shoulder/physiology , Somatosensory Cortex/physiology , Time Factors
14.
Oncogene ; 26(40): 5911-8, 2007 Aug 30.
Article in English | MEDLINE | ID: mdl-17384680

ABSTRACT

Germline LKB1 mutations cause Peutz-Jeghers syndrome, a hereditary disorder that predisposes to gastrointestinal hamartomatous polyposis and several types of malignant tumors. Somatic LKB1 alterations are rare in sporadic cancers, however, a few reports showed the presence of somatic alterations in a considerable fraction of lung cancers. To determine the prevalence and the specificity of LKB1 alterations in lung cancers, we examined a large number of lung cancer cell lines and lung adenocarcinoma (AdC) specimens for the alterations. LKB1 genetic alterations were frequently detected in the cell lines (21/70, 30%), especially in non-small cell lung cancers (NSCLCs) (20/51, 39%), and were significantly more frequent in cell lines with KRAS mutations. Point mutations were detected only in AdCs and large cell carcinomas, whereas homozygous deletions were detected in all histological types of lung cancer. Among lung AdC specimens, LKB1 mutations were found in seven (8%) of 91 male smokers but in none of 64 females and/or nonsmokers, and were significantly more frequent in poorly differentiated tumors. The difference in the frequency of LKB1 alterations between cell lines and tumor specimens was likely to be owing to masking of deletions by the contamination of noncancerous cells in the tumor specimens. These results indicate that somatic LKB1 genetic alterations preferentially occur in a subset of poorly differentiated lung AdCs that appear to correlate with smoking males.


Subject(s)
Carcinoma/genetics , Gene Expression Regulation, Neoplastic , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , Mutation , Protein Serine-Threonine Kinases/genetics , AMP-Activated Protein Kinase Kinases , Aged , Base Sequence , Cell Line, Tumor , Female , Humans , Male , Middle Aged , Molecular Sequence Data , Prevalence , Smoking
15.
Neuroscience ; 142(4): 1273-80, 2006 Nov 03.
Article in English | MEDLINE | ID: mdl-16996219

ABSTRACT

The raphe nucleus has a variety of physiological functions, including emotion, regulation of skeletal muscle motoneurons, spinal transmission of nociceptive signals, sleep, respiration, gastric motility, and cardiovascular function. Recent evidence has shown that centrally administered serotonin has modulatory effects on micturition function, and that decreased brain serotonin might underlie depression and an overactive bladder. We applied high-frequency stimulation (HFS; 0.2-ms duration, 100 Hz) in the raphe nucleus and the adjacent midline area in 20 supracollicular decerebrate cats, which mostly elicited inhibition of the micturition reflex. The effective amplitude of the electrical stimulation for evoking inhibitory responses was less than 50 muA. We also examined single neuronal activities in the raphe nucleus in response to isovolumetric spontaneous micturition reflexes. In total, 79 neurons were recorded in the raphe nucleus that were related to urinary storage/micturition cycles. Of the neurons recorded, the most common were tonic storage neurons (48%), followed by tonic micturition neurons (28%), phasic storage neurons (18%), and phasic micturition neurons (6%). In addition to the tonic/phasic as well as storage/micturition classification, the neurons showed diverse discharge patterns: augmenting, constant and decrementing, with the constant discharge pattern being most common. Among neurons in the raphe nucleus, the neurons with a decrementing discharge pattern were concentrated in the rostral portion, whereas the augmenting and constant neurons existed diffusely. The storage and micturition neurons were intermingled in the rostral portion, whereas they were separate in the caudal portion. In conclusion, the results of the present study indicate that HFS of the raphe area inhibits the micturition reflex and that there are micturition-related neuronal firings in the raphe area in cats, suggesting that the raphe nucleus is involved in neural control of micturition.


Subject(s)
Efferent Pathways/physiology , Neurons/physiology , Raphe Nuclei/physiology , Reflex/physiology , Rhombencephalon/physiology , Urination/physiology , Action Potentials/physiology , Animals , Cats , Efferent Pathways/anatomy & histology , Electric Stimulation , Male , Raphe Nuclei/anatomy & histology , Rhombencephalon/anatomy & histology , Serotonin/deficiency , Spinal Cord/physiology , Urinary Bladder/innervation , Urinary Bladder/physiology , Urinary Bladder, Neurogenic/metabolism , Urinary Bladder, Neurogenic/physiopathology
17.
Eur Respir J ; 23(6): 885-90, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15219002

ABSTRACT

In order to examine the pathology in patients with obstructive sleep apnoea/hypopnoea syndrome (OSAHS), the nonlinear properties of respiratory movement and breath-to-breath variations during resting wakefulness with eyes closed was investigated. Recording of the respiratory movement using inductive plethysmography was performed on 14 patients with OSAHS and 13 control subjects for 2 h in the supine position during daytime. To calculate the correlation dimension (D2) for respiratory movement, an algorithm proposed by Grassberger and Procaccia was applied. The indices of breath-to-breath variations were estimated. To calculate D2 and breath-to-breath variations, two different segments were selected (200 s each). The value of D2 for respiratory movement in patients with OSAHS was significantly greater than that in control subjects. In the case of > or = 2.0 of D2 for respiratory movement, the sensitivity and specificity of detecting the presence of OSAHS was 85.7% and 76.9%, respectively. On the basis of breath-to-breath variations, only the coefficient of variation of expiratory time for respiratory movement in patients with OSAHS was significantly greater than that in the control subjects. In conclusion, the measurements of correlation dimensions for respiratory movement with a brief period during wakefulness may be a useful index for identifying patients with obstructive sleep apnoea/hypopnoea syndrome.


Subject(s)
Respiratory Mechanics/physiology , Sleep Apnea, Obstructive/physiopathology , Adult , Algorithms , Humans , Male , Middle Aged , Models, Biological , Nonlinear Dynamics , Plethysmography , Regression Analysis , Statistics, Nonparametric , Supine Position , Wakefulness
18.
Diabet Med ; 21(6): 559-62, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15154939

ABSTRACT

AIMS: To investigate the relationship between autoantibodies to glutamic acid decarboxylase (GAD) and proliferative diabetic retinopathy (PDR) to assess the role of autoimmunity in retinopathy. METHODS: Patients with Type 1 diabetes for more than 10 years who had been diagnosed under age 30 (13-28 years) were studied. They were classified into three groups. The PDR group consisted of 22 patients, the pre-PDR group was 26 patients, while the non-DR group was 32 patients who had Type 1 diabetes without retinopathy. Blood was collected to measure autoantibodies to GAD, and the relationship between PDR and GAD positivity was investigated in a cross-sectional study. RESULTS: The highest positivity rate of GAD autoantibodies was 50.0% in the non-DR group, followed by the pre-PDR group (30.8%) and the PDR group (18.2%). CONCLUSIONS: Production or existence of GAD autoantibodies may contribute to the prevention of retinopathy.


Subject(s)
Autoantibodies/blood , Diabetes Mellitus, Type 1/immunology , Diabetic Retinopathy/immunology , Glutamate Decarboxylase/immunology , Adolescent , Adult , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/complications , Diabetic Retinopathy/blood , Diabetic Retinopathy/complications , Disease Progression , Female , Humans , Male
20.
Diabetologia ; 47(12): 2145-51, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15662555

ABSTRACT

AIMS/HYPOTHESIS: Several studies have reported that coffee has a protective effect against the development of type 2 diabetes. However, few of these studies used the standard glucose tolerance test to diagnose type 2 diabetes. The aim of this study was to investigate the relationship between coffee and green tea consumption and glucose tolerance status as determined using a 75-g OGTT. METHODS: We performed a cross-sectional study of 3224 male officials of the self-defence forces. Glucose tolerance status was determined in accordance with the 1998 World Health Organization criteria, and average intakes of coffee and green tea over the previous year were assessed by a self-administered questionnaire. The figures obtained were adjusted for BMI, physical activity and other factors. RESULTS: A total of 1130 men were identified as having glucose intolerance (IFG, IGT or type 2 diabetes). Compared with those who did not consume coffee on a daily basis, fasting and 2-h post-load plasma glucose levels were 1.5% and 4.3% lower in those who drank 5 cups of coffee or more per day respectively. The adjusted odds ratios of glucose intolerance for categories of <1, 1-2, 3-4 and >/=5 cups of coffee per day were 1.0 (referent), 0.8 (95% CI 0.6-1.0), 0.7 (95% CI 0.6-0.9) and 0.7 (95% CI 0.5-0.9) respectively (p=0.0001 for trend). No clear association was observed between green tea drinking and glucose tolerance status. CONCLUSIONS/INTERPRETATION: Coffee consumption may inhibit postprandial hyperglycaemia and thereby protect against the development of type 2 diabetes mellitus.


Subject(s)
Blood Glucose/metabolism , Coffee , Diabetes Mellitus, Type 2/epidemiology , Tea , Alcohol Drinking , Cross-Sectional Studies , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/diagnosis , Glucose Tolerance Test , Humans , Japan/epidemiology , Male , Middle Aged , Risk Factors , Smoking
SELECTION OF CITATIONS
SEARCH DETAIL
...